Fair Value of Assets and Liabilities (Tables)
|
9 Months Ended |
Sep. 30, 2015 |
Fair Value Disclosures [Abstract] |
|
Schedule of assets and liabilities that are measured at fair value on a recurring and non-recurring basis |
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of September 30, 2015. | | | | | | | | | | | | | | | | | | | | | ($ in millions) | Quoted prices in active markets for identical assets (Level 1) | | Significant other observable inputs (Level 2) | | Significant unobservable inputs (Level 3) | | Counterparty and cash collateral netting | | Balance as of September 30, 2015 | Assets | |
| | |
| | |
| | |
| | |
| Fixed income securities: | |
| | |
| | |
| | |
| | |
| U.S. government and agencies | $ | 2,851 |
| | $ | 904 |
| | $ | 5 |
| | |
| | $ | 3,760 |
| Municipal | — |
| | 7,305 |
| | 189 |
| | |
| | 7,494 |
| Corporate | — |
| | 41,029 |
| | 600 |
| | |
| | 41,629 |
| Foreign government | — |
| | 1,085 |
| | — |
| | |
| | 1,085 |
| ABS | — |
| | 2,529 |
| | 182 |
| | |
| | 2,711 |
| RMBS | — |
| | 1,010 |
| | 1 |
| | |
| | 1,011 |
| CMBS | — |
| | 523 |
| | 19 |
| | |
| | 542 |
| Redeemable preferred stock | — |
| | 25 |
| | — |
| | |
| | 25 |
| Total fixed income securities | 2,851 |
| | 54,410 |
| | 996 |
| | |
| | 58,257 |
| Equity securities | 3,925 |
| | 170 |
| | 141 |
| | |
| | 4,236 |
| Short-term investments | 351 |
| | 2,645 |
| | 40 |
| | |
| | 3,036 |
| Other investments: Free-standing derivatives | — |
| | 42 |
| | 1 |
| | $ | (14 | ) | | 29 |
| Separate account assets | 3,677 |
| | — |
| | — |
| | |
| | 3,677 |
| Other assets | 2 |
| | — |
| | 1 |
| | |
| | 3 |
| Total recurring basis assets | 10,806 |
| | 57,267 |
| | 1,179 |
| | (14 | ) | | 69,238 |
| Non-recurring basis (1) | — |
| | — |
| | 25 |
| | |
| | 25 |
| Total assets at fair value | $ | 10,806 |
| | $ | 57,267 |
| | $ | 1,204 |
| | $ | (14 | ) | | $ | 69,263 |
| % of total assets at fair value | 15.6 | % | | 82.7 | % | | 1.7 | % | | — | % | | 100 | % | | | | | | | | | | | Liabilities | |
| | |
| | |
| | |
| | |
| Contractholder funds: Derivatives embedded in life and annuity contracts | $ | — |
| | $ | — |
| | $ | (295 | ) | | |
| | $ | (295 | ) | Other liabilities: Free-standing derivatives | (5 | ) | | (14 | ) | | (9 | ) | | $ | 5 |
| | (23 | ) | Total liabilities at fair value | $ | (5 | ) | | $ | (14 | ) | | $ | (304 | ) | | $ | 5 |
| | $ | (318 | ) | % of total liabilities at fair value | 1.6 | % | | 4.4 | % | | 95.6 | % | | (1.6 | )% | | 100 | % |
_______________ | | (1) | Includes $8 million of limited partnership interests and $17 million of other investments written-down to fair value in connection with recognizing other-than-temporary impairments. |
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of December 31, 2014. | | | | | | | | | | | | | | | | | | | | | ($ in millions) | Quoted prices in active markets for identical assets (Level 1) | | Significant other observable inputs (Level 2) | | Significant unobservable inputs (Level 3) | | Counterparty and cash collateral netting | | Balance as of December 31, 2014 | Assets | |
| | |
| | |
| | |
| | |
| Fixed income securities: | |
| | |
| | |
| | |
| | |
| U.S. government and agencies | $ | 3,240 |
| | $ | 1,082 |
| | $ | 6 |
| | |
| | $ | 4,328 |
| Municipal | — |
| | 8,227 |
| | 270 |
| | |
| | 8,497 |
| Corporate | — |
| | 41,253 |
| | 891 |
| | |
| | 42,144 |
| Foreign government | — |
| | 1,645 |
| | — |
| | |
| | 1,645 |
| ABS | — |
| | 3,782 |
| | 196 |
| | |
| | 3,978 |
| RMBS | — |
| | 1,206 |
| | 1 |
| | |
| | 1,207 |
| CMBS | — |
| | 592 |
| | 23 |
| | |
| | 615 |
| Redeemable preferred stock | — |
| | 26 |
| | — |
| | |
| | 26 |
| Total fixed income securities | 3,240 |
| | 57,813 |
| | 1,387 |
| | |
| | 62,440 |
| Equity securities | 3,787 |
| | 234 |
| | 83 |
| | |
| | 4,104 |
| Short-term investments | 692 |
| | 1,843 |
| | 5 |
| | |
| | 2,540 |
| Other investments: Free-standing derivatives | — |
| | 95 |
| | 2 |
| | $ | (5 | ) | | 92 |
| Separate account assets | 4,396 |
| | — |
| | — |
| | |
| | 4,396 |
| Other assets | 2 |
| | — |
| | 1 |
| | |
| | 3 |
| Total recurring basis assets | 12,117 |
| | 59,985 |
| | 1,478 |
| | (5 | ) | | 73,575 |
| Non-recurring basis (1) | — |
| | — |
| | 9 |
| | |
| | 9 |
| Total assets at fair value | $ | 12,117 |
| | $ | 59,985 |
| | $ | 1,487 |
| | $ | (5 | ) | | $ | 73,584 |
| % of total assets at fair value | 16.5 | % | | 81.5 | % | | 2.0 | % | | — | % | | 100 | % | | | | | | | | | | | Liabilities | |
| | |
| | |
| | |
| | |
| Contractholder funds: Derivatives embedded in life and annuity contracts | $ | — |
| | $ | — |
| | $ | (323 | ) | | |
| | $ | (323 | ) | Other liabilities: Free-standing derivatives | (1 | ) | | (50 | ) | | (9 | ) | | $ | 22 |
| | (38 | ) | Total liabilities at fair value | $ | (1 | ) | | $ | (50 | ) | | $ | (332 | ) | | $ | 22 |
| | $ | (361 | ) | % of total liabilities at fair value | 0.3 | % | | 13.8 | % | | 92.0 | % | | (6.1 | )% | | 100 | % |
_______________ | | (1) | Includes $6 million of mortgage loans and $3 million of limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments. |
|
Summary of quantitative information about the significant unobservable inputs |
The following table summarizes quantitative information about the significant unobservable inputs used in Level 3 fair value measurements. | | | | | | | | | | | | | ($ in millions) | Fair value | | Valuation technique | | Unobservable input | | Range | | Weighted average | September 30, 2015 | |
| | | | | | | | | Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options | $ | (242 | ) | | Stochastic cash flow model | | Projected option cost | | 1.0 - 2.2% | | 1.76% | December 31, 2014 | |
| | | | | | | | | Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options | $ | (278 | ) | | Stochastic cash flow model | | Projected option cost | | 1.0 - 2.0% | | 1.76% |
|
Schedule of the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis |
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2015. | | | | | | | | | | | | | | | | | | | | | | ($ in millions) | |
| | Total gains (losses) included in: | | |
| | |
| | | Balance as of June 30, 2015 | | Net income (1) | | OCI | | Transfers into Level 3 | | Transfers out of Level 3 | | Assets | |
| | |
| | |
| | |
| | |
| | Fixed income securities: | |
| | |
| | |
| | |
| | |
| | U.S. government and agencies | $ | 5 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | Municipal | 215 |
| | 3 |
| | — |
| | 3 |
| | — |
| | Corporate | 626 |
| | 11 |
| | (10 | ) | | — |
| | (24 | ) | | ABS | 120 |
| | — |
| | (1 | ) | | 31 |
| | — |
| | RMBS | 1 |
| | — |
| | — |
| | — |
| | — |
| | CMBS | 28 |
| | — |
| | — |
| | — |
| | — |
| | Total fixed income securities | 995 |
| | 14 |
| | (11 | ) | | 34 |
| | (24 | ) | | Equity securities | 108 |
| | (2 | ) | | (3 | ) | | — |
| | — |
| | Short-term investments | 35 |
| | — |
| | — |
| | — |
| | — |
| | Free-standing derivatives, net | (7 | ) | | (1 | ) | | — |
| | — |
| | — |
| | Other assets | 1 |
| | — |
| | — |
| | — |
| | — |
| | Total recurring Level 3 assets | $ | 1,132 |
| | $ | 11 |
| | $ | (14 | ) | | $ | 34 |
| | $ | (24 | ) | | | | | | | | | | | | | Liabilities | | | | | | | | | | | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | (315 | ) | | $ | 19 |
| | $ | — |
| | $ | — |
| | $ | — |
| | Total recurring Level 3 liabilities | $ | (315 | ) | | $ | 19 |
| | $ | — |
| | $ | — |
| | $ | — |
| | | | | | | | | | | | | | Purchases | | Sales | | Issues | | Settlements | | Balance as of September 30, 2015 | | Assets | |
| | |
| | |
| | |
| | | | Fixed income securities: | |
| | |
| | |
| | |
| | | | U.S. government and agencies | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 5 |
| | Municipal | — |
| | (32 | ) | | — |
| | — |
| | 189 |
| | Corporate | 10 |
| | (11 | ) | | — |
| | (2 | ) | | 600 |
| | ABS | 60 |
| | — |
| | — |
| | (28 | ) | | 182 |
| | RMBS | — |
| | — |
| | — |
| | — |
| | 1 |
| | CMBS | 4 |
| | — |
| | — |
| | (13 | ) | | 19 |
| | Total fixed income securities | 74 |
| | (43 | ) | | — |
| | (43 | ) | | 996 |
| | Equity securities | 38 |
| | — |
| | — |
| | — |
| | 141 |
| | Short-term investments | 5 |
| | — |
| | — |
| | — |
| | 40 |
| | Free-standing derivatives, net | — |
| | — |
| | — |
| | — |
| | (8 | ) | (2) | Other assets | — |
| | — |
| | — |
| | — |
| | 1 |
| | Total recurring Level 3 assets | $ | 117 |
| | $ | (43 | ) | | $ | — |
| | $ | (43 | ) | | $ | 1,170 |
| | | | | | | | | | | | | Liabilities | | | | | | | | | | | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1 |
| | $ | (295 | ) | | Total recurring Level 3 liabilities | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1 |
| | $ | (295 | ) | |
_____________ | | (1) | The effect to net income totals $30 million and is reported in the Condensed Consolidated Statements of Operations as follows: $8 million in realized capital gains and losses, $3 million in net investment income, $27 million in interest credited to contractholder funds and $(8) million in life and annuity contract benefits. |
| | (2) | Comprises $1 million of assets and $9 million of liabilities. |
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the nine months ended September 30, 2015. | | | | | | | | | | | | | | | | | | | | | | ($ in millions) | |
| | Total gains (losses) included in: | | |
| | |
| | | Balance as of December 31, 2014 | | Net income (1) | | OCI | | Transfers into Level 3 | | Transfers out of Level 3 | | Assets | |
| | |
| | |
| | |
| | |
| | Fixed income securities: | |
| | |
| | |
| | |
| | |
| | U.S. government and agencies | $ | 6 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | Municipal | 270 |
| | 5 |
| | (4 | ) | | 3 |
| | (2 | ) | | Corporate | 891 |
| | 11 |
| | (16 | ) | | 5 |
| | (232 | ) | | ABS | 196 |
| | (2 | ) | | 1 |
| | 43 |
| | (84 | ) | | RMBS | 1 |
| | — |
| | — |
| | — |
| | — |
| | CMBS | 23 |
| | — |
| | — |
| | — |
| | — |
| | Total fixed income securities | 1,387 |
| | 14 |
| | (19 | ) | | 51 |
| | (318 | ) | | Equity securities | 83 |
| | (1 | ) | | 1 |
| | — |
| | — |
| | Short-term investments | 5 |
| | — |
| | — |
| | — |
| | — |
| | Free-standing derivatives, net | (7 | ) | | — |
| | — |
| | — |
| | — |
| | Other assets | 1 |
| | — |
| | — |
| | — |
| | — |
| | Total recurring Level 3 assets | $ | 1,469 |
| | $ | 13 |
| | $ | (18 | ) | | $ | 51 |
| | $ | (318 | ) | | | | | | | | | | | | | Liabilities | | | | | | | | | | | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | (323 | ) | | $ | 24 |
| | $ | — |
| | $ | — |
| | $ | — |
| | Total recurring Level 3 liabilities | $ | (323 | ) | | $ | 24 |
| | $ | — |
| | $ | — |
| | $ | — |
| | | | | | | | | | | | | | Purchases | | Sales | | Issues | | Settlements | | Balance as of September 30, 2015 | | Assets | |
| | |
| | |
| | |
| | | | Fixed income securities: | |
| | |
| | |
| | |
| | | | U.S. government and agencies | $ | — |
| | $ | — |
| | $ | — |
| | $ | (1 | ) | | $ | 5 |
| | Municipal | — |
| | (81 | ) | | — |
| | (2 | ) | | 189 |
| | Corporate | 70 |
| | (57 | ) | | — |
| | (72 | ) | | 600 |
| | ABS | 70 |
| | (5 | ) | | — |
| | (37 | ) | | 182 |
| | RMBS | — |
| | — |
| | — |
| | — |
| | 1 |
| | CMBS | 9 |
| | — |
| | — |
| | (13 | ) | | 19 |
| | Total fixed income securities | 149 |
| | (143 | ) | | — |
| | (125 | ) | | 996 |
| | Equity securities | 58 |
| | — |
| | — |
| | — |
| | 141 |
| | Short-term investments | 35 |
| | — |
| | — |
| | — |
| | 40 |
| | Free-standing derivatives, net | — |
| | — |
| | — |
| | (1 | ) | | (8 | ) | (2) | Other assets | — |
| | — |
| | — |
| | — |
| | 1 |
| | Total recurring Level 3 assets | $ | 242 |
| | $ | (143 | ) | | $ | — |
| | $ | (126 | ) | | $ | 1,170 |
| | | | | | | | | | | | | Liabilities | | | | | | | | | | | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | — |
| | $ | — |
| | $ | (1 | ) | | $ | 5 |
| | $ | (295 | ) | | Total recurring Level 3 liabilities | $ | — |
| | $ | — |
| | $ | (1 | ) | | $ | 5 |
| | $ | (295 | ) | |
_____________ | | (1) | The effect to net income totals $37 million and is reported in the Condensed Consolidated Statements of Operations as follows: $4 million in realized capital gains and losses, $9 million in net investment income, $32 million in interest credited to contractholder funds and $(8) million in life and annuity contract benefits. |
| | (2) | Comprises $1 million of assets and $9 million of liabilities. |
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2014. | | | | | | | | | | | | | | | | | | | | | | ($ in millions) | | | Total gains (losses) included in: | | | | | | | Balance as of June 30, 2014 | | Net income (1) | | OCI | | Transfers into Level 3 | | Transfers out of Level 3 | | Assets | |
| | |
| | |
| | |
| | |
| | Fixed income securities: | |
| | |
| | |
| | |
| | |
| | U.S. government and agencies | $ | 6 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | Municipal | 302 |
| | — |
| | (7 | ) | | — |
| | — |
| | Corporate | 965 |
| | 4 |
| | (14 | ) | | 23 |
| | — |
| | ABS | 142 |
| | 1 |
| | 1 |
| | — |
| | (20 | ) | | RMBS | 1 |
| | — |
| | — |
| | — |
| | — |
| | CMBS | 55 |
| | (1 | ) | | — |
| | — |
| | — |
| | Total fixed income securities | 1,471 |
| | 4 |
| | (20 | ) | | 23 |
| | (20 | ) | | Equity securities | 19 |
| | — |
| | — |
| | — |
| | — |
| | Free-standing derivatives, net | (5 | ) | | — |
| | — |
| | — |
| | — |
| | Other assets | 1 |
| | — |
| | — |
| | — |
| | — |
| | Total recurring Level 3 assets | $ | 1,486 |
| | $ | 4 |
| | $ | (20 | ) | | $ | 23 |
| | $ | (20 | ) | | | | | | | | | | | | | Liabilities | | | | | | | | | | | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | (331 | ) | | $ | 9 |
| | $ | — |
| | $ | — |
| | $ | — |
| | Total recurring Level 3 liabilities | $ | (331 | ) | | $ | 9 |
| | $ | — |
| | $ | — |
| | $ | — |
| | | | | | | | | | | | | | Purchases | | Sales | | Issues | | Settlements | | Balance as of September 30, 2014 | | Assets | |
| | |
| | |
| | |
| | |
| | Fixed income securities: | |
| | |
| | |
| | |
| | |
| | U.S. government and agencies | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 6 |
| | Municipal | 5 |
| | (15 | ) | | — |
| | 5 |
| | 290 |
| | Corporate | 24 |
| | (12 | ) | | — |
| | (54 | ) | | 936 |
| | ABS | 55 |
| | — |
| | — |
| | (5 | ) | | 174 |
| | RMBS | — |
| | — |
| | — |
| | — |
| | 1 |
| | CMBS | 3 |
| | — |
| | — |
| | (3 | ) | | 54 |
| | Total fixed income securities | 87 |
| | (27 | ) | | — |
| | (57 | ) | | 1,461 |
| | Equity securities | 64 |
| | — |
| | — |
| | — |
| | 83 |
| | Free-standing derivatives, net | — |
| | — |
| | — |
| | (1 | ) | | (6 | ) | (2) | Other assets | — |
| | — |
| | — |
| | — |
| | 1 |
| | Total recurring Level 3 assets | $ | 151 |
| | $ | (27 | ) | | $ | — |
| | $ | (58 | ) | | $ | 1,539 |
| | | | | | | | | | | | | Liabilities | |
| | |
| | |
| | |
| | |
| | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1 |
| | $ | (321 | ) | | Total recurring Level 3 liabilities | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1 |
| | $ | (321 | ) | |
_____________________ | | (1) | The effect to net income totals $13 million and is reported in the Condensed Consolidated Statements of Operations as follows: $4 million in net investment income, $5 million in interest credited to contractholder funds and $4 million in life and annuity contract benefits. |
| | (2) | Comprises $3 million of assets and $9 million of liabilities. |
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the nine months ended September 30, 2014. | | | | | | | | | | | | | | | | | | | | | | ($ in millions) | | | Total gains (losses) included in: | | | | | | | Balance as of December 31, 2013 | | Net income (1) | | OCI | | Transfers into Level 3 | | Transfers out of Level 3 | | Assets | |
| | |
| | |
| | |
| | |
| | Fixed income securities: | |
| | |
| | |
| | |
| | |
| | U.S. government and agencies | $ | 7 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | Municipal | 343 |
| | (4 | ) | | 4 |
| | — |
| | (17 | ) | | Corporate | 1,109 |
| | 17 |
| | (4 | ) | | 23 |
| | (37 | ) | | ABS | 192 |
| | 1 |
| | 1 |
| | — |
| | (121 | ) | | RMBS | 2 |
| | — |
| | — |
| | — |
| | — |
| | CMBS | 43 |
| | (1 | ) | | — |
| | 5 |
| | — |
| | Redeemable preferred stock | 1 |
| | — |
| | — |
| | — |
| | — |
| | Total fixed income securities | 1,697 |
| | 13 |
| | 1 |
| | 28 |
| | (175 | ) | | Equity securities | 132 |
| | 22 |
| | (15 | ) | | — |
| | — |
| | Short-term investments | — |
| | — |
| | — |
| | — |
| | — |
| | Free-standing derivatives, net | (5 | ) | | 1 |
| | — |
| | — |
| | — |
| | Other assets | — |
| | 1 |
| | — |
| | — |
| | — |
| | Assets held for sale | 362 |
| | (1 | ) | | 2 |
| | 4 |
| | (2 | ) | | Total recurring Level 3 assets | $ | 2,186 |
| | $ | 36 |
| | $ | (12 | ) | | $ | 32 |
| | $ | (177 | ) | | | | | | | | | | | | | Liabilities | | | | | | | | | | | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | (307 | ) | | $ | (5 | ) | | $ | — |
| | $ | — |
| | $ | — |
| | Liabilities held for sale | (246 | ) | | 17 |
| | — |
| | — |
| | — |
| | Total recurring Level 3 liabilities | $ | (553 | ) | | $ | 12 |
| | $ | — |
| | $ | — |
| | $ | — |
| | | | | | | | | | | | | | Sold in LBL disposition (3) | | Purchases/ Issues (4) | | Sales | | Settlements | | Balance as of September 30, 2014 | | Assets | |
| | |
| | |
| | |
| | |
| | Fixed income securities: | |
| | |
| | |
| | |
| | |
| | U.S. government and agencies | $ | — |
| | $ | — |
| | $ | — |
| | $ | (1 | ) | | $ | 6 |
| | Municipal | — |
| | 6 |
| | (41 | ) | | (1 | ) | | 290 |
| | Corporate | — |
| | 56 |
| | (123 | ) | | (105 | ) | | 936 |
| | ABS | — |
| | 119 |
| | — |
| | (18 | ) | | 174 |
| | RMBS | — |
| | — |
| | — |
| | (1 | ) | | 1 |
| | CMBS | 4 |
| | 8 |
| | (1 | ) | | (4 | ) | | 54 |
| | Redeemable preferred stock | — |
| | — |
| | (1 | ) | | — |
| | — |
| | Total fixed income securities | 4 |
| | 189 |
| | (166 | ) | | (130 | ) | | 1,461 |
| | Equity securities | — |
| | 67 |
| | (123 | ) | | — |
| | 83 |
| | Short-term investments | — |
| | 40 |
| | (40 | ) | | — |
| | — |
| | Free-standing derivatives, net | — |
| | 2 |
| | — |
| | (4 | ) | | (6 | ) | (2) | Other assets | — |
| | — |
| | — |
| | — |
| | 1 |
| | Assets held for sale | (351 | ) | | — |
| | (8 | ) | | (6 | ) | | — |
| | Total recurring Level 3 assets | $ | (347 | ) | | $ | 298 |
| | $ | (337 | ) | | $ | (140 | ) | | $ | 1,539 |
| | | | | | | | | | | | | Liabilities | |
| | |
| | |
| | |
| | |
| | Contractholder funds: Derivatives embedded in life and annuity contracts | $ | — |
| | $ | (13 | ) | | $ | — |
| | $ | 4 |
| | $ | (321 | ) | | Liabilities held for sale | 230 |
| | (4 | ) | | — |
| | 3 |
| | — |
| | Total recurring Level 3 liabilities | $ | 230 |
| | $ | (17 | ) | | $ | — |
| | $ | 7 |
| | $ | (321 | ) | |
_____________________ | | (1) | The effect to net income totals $48 million and is reported in the Condensed Consolidated Statements of Operations as follows: $29 million in realized capital gains and losses, $10 million in net investment income, $5 million in interest credited to contractholder funds, $8 million in life and annuity contract benefits and $(4) million in loss on disposition of operations. |
| | (2) | Comprises $3 million of assets and $9 million of liabilities. |
| | (3) | Includes transfers from held for sale that took place in first quarter 2014 of $4 million for CMBS and $(4) million for Assets held for sale. |
| | (4) | Represents purchases for assets and issues for liabilities. |
|
Schedule of gains and losses included in net income for Level 3 assets and liabilities still held at the balance sheet date |
The following table provides the change in unrealized gains and losses included in net income for Level 3 assets and liabilities held as of September 30. | | | | | | | | | | | | | | | | | ($ in millions) | Three months ended September 30, | | Nine months ended September 30, | | 2015 | | 2014 | | 2015 | | 2014 | Assets | |
| | |
| | |
| | |
| Fixed income securities: | |
| | |
| | |
| | |
| Municipal | $ | — |
| | $ | (3 | ) | | $ | (1 | ) | | $ | (8 | ) | Corporate | 3 |
| | 3 |
| | 7 |
| | 8 |
| ABS | (1 | ) | | — |
| | 3 |
| | — |
| RMBS | — |
| | — |
| | — |
| | (1 | ) | CMBS | — |
| | (1 | ) | | — |
| | (1 | ) | Total fixed income securities | 2 |
| | (1 | ) | | 9 |
| | (2 | ) | Equity securities | (2 | ) | | — |
| | (2 | ) | | — |
| Free-standing derivatives, net | (1 | ) | | — |
| | — |
| | 6 |
| Other assets | — |
| | — |
| | — |
| | 1 |
| Assets held for sale | — |
| | — |
| | — |
| | (1 | ) | Total recurring Level 3 assets | $ | (1 | ) | | $ | (1 | ) | | $ | 7 |
| | $ | 4 |
| Liabilities | |
| | |
| | |
| | |
| Contractholder funds: Derivatives embedded in life and annuity contracts | $ | 19 |
| | $ | 9 |
| | $ | 24 |
| | $ | (5 | ) | Liabilities held for sale | — |
| | — |
| | — |
| | 17 |
| Total recurring Level 3 liabilities | $ | 19 |
| | $ | 9 |
| | $ | 24 |
| | $ | 12 |
|
|
Schedule of carrying values and fair value estimates of financial instruments not carried at fair value |
Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value. Financial assets | | | | | | | | | | | | | | | | | ($ in millions) | September 30, 2015 | | December 31, 2014 | | Carrying value | | Fair value | | Carrying value | | Fair value | Mortgage loans | $ | 4,402 |
| | $ | 4,615 |
| | $ | 4,188 |
| | $ | 4,446 |
| Cost method limited partnerships | 1,148 |
| | 1,506 |
| | 1,122 |
| | 1,488 |
| Bank loans | 1,839 |
| | 1,820 |
| | 1,663 |
| | 1,638 |
| Agent loans | 416 |
| | 406 |
| | 368 |
| | 361 |
|
| | | | | | | | | | | | | | | | | ($ in millions) | September 30, 2015 | | December 31, 2014 | | Carrying value | | Fair value | | Carrying value | | Fair value | Contractholder funds on investment contracts | $ | 12,718 |
| | $ | 13,225 |
| | $ | 13,734 |
| | $ | 14,390 |
| Long-term debt | 5,175 |
| | 5,695 |
| | 5,194 |
| | 5,835 |
| Liability for collateral | 783 |
| | 783 |
| | 782 |
| | 782 |
|
|